Cargando…
Ultrasound-Triggered Release of 5-Fluorouracil from Soy Lecithin Echogenic Liposomes
Colorectal cancer is the third most diagnosed cancer and the second leading cause of death. The use of 5-fluorouracil (5-FU) has been the major chemotherapeutic treatment for colorectal cancer patients. However, the efficacy of 5-FU is limited by drug resistance, and bone marrow toxicity through hig...
Autores principales: | Ezekiel, Charles Izuchukwu, Bapolisi, Alain Murhimalika, Walker, Roderick Bryan, Krause, Rui Werner Maçedo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229429/ https://www.ncbi.nlm.nih.gov/pubmed/34205990 http://dx.doi.org/10.3390/pharmaceutics13060821 |
Ejemplares similares
-
pH-Triggered Echogenicity and Contents Release from
Liposomes
por: Nahire, Rahul, et al.
Publicado: (2014) -
Development and In Vitro Evaluation of Liposomes Using Soy Lecithin to Encapsulate Paclitaxel
por: Nguyen, Thi Lan, et al.
Publicado: (2017) -
Preparation of Liposomes from Soy Lecithin Using Liquefied Dimethyl Ether
por: Kanda, Hideki, et al.
Publicado: (2021) -
Soy Lecithin-Derived Liposomal Delivery Systems: Surface Modification and Current Applications
por: Le, Ngoc Thuy Trang, et al.
Publicado: (2019) -
Stable, Monodisperse, and Highly Cell-Permeating Nanocochleates from Natural Soy Lecithin Liposomes
por: Asprea, Martina, et al.
Publicado: (2019)